Study for ELNEC 4: Symptom Management in Palliative Care Test with flashcards and multiple choice questions. Hints and explanations included! Get ready for your exam!

Multiple Choice

How should breakthrough pain be treated in a patient receiving continuous opioid therapy?

Breakthrough pain is a brief, rapid flare of pain on top of ongoing opioid therapy, so it’s treated with a fast-acting opioid rather than trying to adjust the long-acting dose. The goal is to deliver analgesia quickly and stop the episode without causing excessive sedation or overdose. Use a rapid-onset opioid whose potency fits the patient’s current opioid exposure. A practical starting approach is about 10–15% of the total 24-hour opioid dose given per breakthrough episode, with the option to repeat every 1–2 hours as needed after reassessment. This dosing mirrors the short, intense nature of breakthrough pain and can be adjusted based on response and tolerability. Discontinue or delay baseline long-acting adjustments for breakthrough episodes, and avoid relying on non-opioid analgesics alone, as they won’t reliably control sudden pain spikes in this context.

Breakthrough pain is a brief, rapid flare of pain on top of ongoing opioid therapy, so it’s treated with a fast-acting opioid rather than trying to adjust the long-acting dose. The goal is to deliver analgesia quickly and stop the episode without causing excessive sedation or overdose.

Use a rapid-onset opioid whose potency fits the patient’s current opioid exposure. A practical starting approach is about 10–15% of the total 24-hour opioid dose given per breakthrough episode, with the option to repeat every 1–2 hours as needed after reassessment. This dosing mirrors the short, intense nature of breakthrough pain and can be adjusted based on response and tolerability.

Discontinue or delay baseline long-acting adjustments for breakthrough episodes, and avoid relying on non-opioid analgesics alone, as they won’t reliably control sudden pain spikes in this context.